The mission of the Bioinformatics Share Resource (BISR) is to provide cutting edge bioinformatics services and collaborative research support to MCCC investigators engaged in genomics studies with high impact on the care of cancer patients. The allied BISR led by Dr. Jean-Pierre Kocher currently counts 7 MS and Ph.D. level allied health bioinformaticians. The service lines offered by the BIC fall in 4 categories: i) preprocessing of omics data including several workflow dedicated to Next Generation Sequencing data analysis, ii) data annotation services critical for the first level interpretation of preprocessed genomics data, iii) data management solution for the integration of large genomics, proteomics and metabolomics datasets iv) data collection services from internal and external data sources (Mayo Biobank, TCGA, GEO, etc.). The BISR also facilitates the collaborative research opportunity between MCCC faculty and Bioinformatics Faculty. The BISR has forged a tight patnership with the Research IT Department for the development of Bioinformatics workflows and systems. About 10 analysts programmers of the Research IT department are supporting the BISR at no additional charge to MCCC. Over the last 5 years, the BISR has worked with 121 MCCC investigators on more than 775 projects. About 60% of these investigators had or have peer reviewed funding. The BISR has faciliated the collaborative engagement of more than 13 bioinformatics faculty on 39 projects led by MCCC investigators. During the same period, BISR faculty and allied health staff were coauthor on over 75 publications during the project period with MCCC investigators. In addition, over the last year, BSIR faculty were listed as key personal on more than 60 submitted grants. BSIR faculty are engaged with the Prostate, Breast, Lymphoma and Ovarian Spores. In the future, the BISR will pursue the development of preprocessing workflows, further implement or develop methods for the advanced interpretation of omics data as well as maintain its educational activities. BISR is now located on all 3 Mayo sites: Mayo Clinic Rochester (MCR), Mayo Clinic Arizona (MCA), and Mayo Clinic Florida (MCF).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Cooperberg, Matthew R; Davicioni, Elai; Crisan, Anamaria et al. (2015) Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort. Eur Urol 67:326-33
Bogenberger, James M; Delman, Devora; Hansen, Nanna et al. (2015) Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies. Leuk Lymphoma 56:226-9
Sami, Sarmed S; Ragunath, Krish; Iyer, Prasad G (2015) Screening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions. Clin Gastroenterol Hepatol 13:623-34
Fackler, Mary Jo; Lopez Bujanda, Zoila; Umbricht, Christopher et al. (2014) Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res 74:2160-70
Porrata, Luis F; Ristow, Kay M; Habermann, Thomas M et al. (2014) Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma. Leuk Lymphoma 55:2728-38
Yoon, Harry H; Tougeron, David; Shi, Qian et al. (2014) KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance). Clin Cancer Res 20:3033-43
Espejo, Rosario; Jeng, Yowjiun; Paulucci-Holthauzen, Adriana et al. (2014) PTP-PEST targets a novel tyrosine site in p120 catenin to control epithelial cell motility and Rho GTPase activity. J Cell Sci 127:497-508
Banck, Michaela S; Beutler, Andreas S (2014) Advances in small bowel neuroendocrine neoplasia. Curr Opin Gastroenterol 30:163-7
Boland, Jennifer M; Wampfler, Jason A; Jang, Jin S et al. (2014) Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts. Am J Surg Pathol 38:1681-8
Imperiale, Thomas F; Ransohoff, David F; Itzkowitz, Steven H et al. (2014) Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 370:1287-97

Showing the most recent 10 out of 340 publications